Press Releases

Press Releases

    Date Title View
    08/19/19
    Summary ToggleHorizon Therapeutics plc to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
    PDF Version
    08/14/19
    Summary ToggleHorizon Therapeutics plc Collaborates with Rare Disease Advocates to Elevate Resources and Shared Experiences Through Launch of #RAREis™ Community Website
    PDF Version
    08/07/19
    Summary ToggleHorizon Therapeutics plc Reports Strong Second-Quarter 2019 Results; Increases Full‐Year 2019 Net Sales and Adjusted EBITDA Guidance
    08/01/19
    Summary ToggleHorizon Therapeutics plc Announces Teprotumumab Expanded Access Program
    PDF Version
    08/01/19
    Summary ToggleHorizon Therapeutics plc Appoints Dr. Sue Mahony to Board of Directors
    PDF Version
    07/25/19
    Summary ToggleHorizon Therapeutics plc Wins International CSR Excellence Award for Partnership with Perspectives Math and Science Academy
    PDF Version
    07/18/19
    Summary ToggleHorizon Therapeutics plc Announces U.S. FDA Acceptance of its New Drug Application to Make PROCYSBI® (Cysteamine Bitartrate) Available as Oral Granules in Packets
    PDF Version
    07/16/19
    Summary ToggleHorizon Therapeutics plc to Release Second-Quarter 2019 Financial Results and Host Webcast on Aug. 7, 2019
    PDF Version
    07/11/19
    Summary ToggleHorizon Therapeutics plc Announces Pricing of Private Offering of Senior Notes
    PDF Version
    07/10/19
    Summary ToggleHorizon Therapeutics plc Announces Proposed Private Offering of Senior Notes
    PDF Version
    Displaying 21 - 30 of 472 results